| Sep 16, 2013
| 3:33 PM
A decade ago, Taymour Tamaddon was an MBA. student with a background in physics trying to convince Baltimore-based money manager T. Rowe Price to hire him as an intern.
Not only did Price give him the internship and hire him later as a health care...
| Dec 1, 2013
| 5:00 AM
The havoc that HIV can wreak on a family and a community can be devastating. Over the past three decades, we have watched helplessly as friends and family members died from HIV-related illnesses. Each one lived life brimming with hope and energy, prepared...
| Aug 27, 2012
| 3:29 PM
(Reuters) - U.S. health regulators on Monday approved Gilead Sciences Inc's four-drug combination pill to treat HIV, the virus that causes AIDS.
The four drugs in one pill, which was formerly called the Quad and had been considered one of Gilead's more...
| Jul 16, 2012
| 4:31 PM
The federal government has approved for the first time a drug that can prevent an HIV infection, a significant development for Baltimore where transmission rates for the virus remain high and growing.
The U.S. Food and Drug Administration approved...
| Jul 18, 2012
| 11:43 AM
LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.
The United Nations...
| Jul 20, 2012
| 2:21 PM
NEW YORK (Reuters) - The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it and suggested that poor and wealthy countries alike set up pilot projects to better...
| Oct 27, 2010
| 1:51 PM
Groups working on a gel to protect women from the AIDS virus say they are moving ahead to develop the product that was hailed as "groundbreaking" after a study on its effectiveness was released in July.
The developers, who met last week with the U.S....
| Jun 14, 2010
| 4:06 PM
In a rare move, federal regulators are seeking to disqualify a prominent Chicago HIV doctor from future drug studies after they discovered his clinic committed one of the most grievous sins of medical research: submitting fictitious data in a drug trial....